|
|
head morphogenesis
|
GO:0060323 |
34 |
0.795
|
|
|
|
female sex differentiation
|
GO:0046660 |
84 |
0.535
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.414
|
|
|
|
platelet derived growth factor receptor signaling pathway
|
GO:0048008 |
32 |
0.409
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.407
|
|
|
|
face development
|
GO:0060324 |
38 |
0.388
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.332
|
|
|
|
development of primary male sexual characteristics
|
GO:0046546 |
88 |
0.289
|
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.281
|
|
|
|
fibroblast migration
|
GO:0010761 |
21 |
0.254
|
|
|
|
gonad development
|
GO:0008406 |
141 |
0.218
|
|
|
|
male sex differentiation
|
GO:0046661 |
109 |
0.214
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.193
|
|
|
|
steroid metabolic process
|
GO:0008202 |
119 |
0.193
|
|
|
|
female gonad development
|
GO:0008585 |
71 |
0.182
|
|
|
|
palate development
|
GO:0060021 |
76 |
0.180
|
|
|
|
estrogen metabolic process
|
GO:0008210 |
8 |
0.166
|
|
|
|
androgen metabolic process
|
GO:0008209 |
11 |
0.165
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.160
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.154
|
|
|
|
antigen receptor mediated signaling pathway
|
GO:0050851 |
64 |
0.140
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.130
|
|
|
|
luteinization
|
GO:0001553 |
8 |
0.118
|
|
|
|
male gonad development
|
GO:0008584 |
88 |
0.116
|
|
|
|
sphingolipid metabolic process
|
GO:0006665 |
45 |
0.112
|
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.104
|
|
|
|
leydig cell differentiation
|
GO:0033327 |
10 |
0.096
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.096
|
|
|
|
hormone metabolic process
|
GO:0042445 |
86 |
0.091
|
|
|
|
b cell receptor signaling pathway
|
GO:0050853 |
20 |
0.087
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.086
|
|
|
|
body morphogenesis
|
GO:0010171 |
45 |
0.081
|
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.080
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.076
|
|
|
|
glycoprotein biosynthetic process
|
GO:0009101 |
89 |
0.076
|
|
|
|
glycosylation
|
GO:0070085 |
62 |
0.075
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.070
|
|
|
|
lateral inhibition
|
GO:0046331 |
1 |
0.069
|
|
|
|
regulation of phospholipase c activity
|
GO:1900274 |
3 |
0.068
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.064
|
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
191 |
0.060
|
|
|
|
immune response regulating cell surface receptor signaling pathway
|
GO:0002768 |
80 |
0.058
|
|
|
|
face morphogenesis
|
GO:0060325 |
29 |
0.058
|
|
|
|
membrane lipid metabolic process
|
GO:0006643 |
53 |
0.055
|
|
|
|
glycoprotein metabolic process
|
GO:0009100 |
116 |
0.054
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.052
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.051
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.049
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.049
|
|
|
|
phosphatidylinositol 3 kinase signaling
|
GO:0014065 |
36 |
0.046
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.044
|
|
|
|
positive regulation of smooth muscle cell migration
|
GO:0014911 |
4 |
0.043
|
|
|
|
macromolecule glycosylation
|
GO:0043413 |
55 |
0.042
|
|
|
|
inositol lipid mediated signaling
|
GO:0048017 |
41 |
0.041
|
|
|
|
immune response regulating signaling pathway
|
GO:0002764 |
125 |
0.041
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.040
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.039
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.037
|
|
|
|
ruffle organization
|
GO:0031529 |
16 |
0.036
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.036
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.036
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.035
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.035
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.034
|
|
|
|
immune response activating signal transduction
|
GO:0002757 |
116 |
0.034
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.033
|
|
|
|
microtubule based process
|
GO:0007017 |
236 |
0.033
|
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.032
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.032
|
|
|
|
development of primary female sexual characteristics
|
GO:0046545 |
73 |
0.032
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.032
|
|
|
|
ovulation cycle
|
GO:0042698 |
59 |
0.031
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.030
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.030
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.030
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.030
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.030
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.029
|
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.029
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
128 |
0.029
|
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.028
|
|
|
|
cellular lipid catabolic process
|
GO:0044242 |
52 |
0.028
|
|
|
|
smooth muscle cell migration
|
GO:0014909 |
10 |
0.028
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.027
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.027
|
|
|
|
response to oxidative stress
|
GO:0006979 |
123 |
0.027
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.027
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.026
|
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.026
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.026
|
|
|
|
muscle cell migration
|
GO:0014812 |
19 |
0.026
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.025
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.025
|
|
|
|
cation transmembrane transport
|
GO:0098655 |
266 |
0.025
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.025
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.025
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.024
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.024
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.024
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.024
|
|
|
|
regulation of ion transmembrane transport
|
GO:0034765 |
119 |
0.024
|
|
|
|
ceramide metabolic process
|
GO:0006672 |
31 |
0.024
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.023
|
|
|
|
regulation of actin cytoskeleton organization
|
GO:0032956 |
84 |
0.023
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.023
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.023
|
|
|
|
negative regulation of cell activation
|
GO:0050866 |
111 |
0.023
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.023
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.022
|
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
207 |
0.022
|
|
|
|
positive regulation of phospholipase activity
|
GO:0010518 |
3 |
0.022
|
|
|
|
actin filament organization
|
GO:0007015 |
113 |
0.022
|
|
|
|
regulation of protein catabolic process
|
GO:0042176 |
108 |
0.021
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.021
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.021
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.021
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.021
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
166 |
0.021
|
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.021
|
|
|
|
fatty acid metabolic process
|
GO:0006631 |
121 |
0.021
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.021
|
|
|
|
protein kinase b signaling
|
GO:0043491 |
74 |
0.021
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.020
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.020
|
|
|
|
regulation of feeding behavior
|
GO:0060259 |
3 |
0.020
|
|
|
|
divalent metal ion transport
|
GO:0070838 |
172 |
0.020
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.020
|
|
|
|
regulation of metal ion transport
|
GO:0010959 |
106 |
0.020
|
|
|
|
calcium ion transport
|
GO:0006816 |
159 |
0.019
|
|
|
|
multicellular organismal signaling
|
GO:0035637 |
91 |
0.019
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.019
|
|
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.019
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.019
|
|
|
|
negative regulation of protein kinase b signaling
|
GO:0051898 |
18 |
0.019
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.019
|
|
|
|
positive regulation of phospholipase c activity
|
GO:0010863 |
2 |
0.019
|
|
|
|
guanosine containing compound catabolic process
|
GO:1901069 |
144 |
0.019
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.018
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.018
|
|
|
|
multi multicellular organism process
|
GO:0044706 |
109 |
0.018
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.018
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.018
|
|
|
|
neuron migration
|
GO:0001764 |
122 |
0.018
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.017
|
|
|
|
regulation of nucleoside metabolic process
|
GO:0009118 |
130 |
0.017
|
|
|
|
activation of immune response
|
GO:0002253 |
138 |
0.017
|
|
|
|
glycerolipid metabolic process
|
GO:0046486 |
122 |
0.017
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.017
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.017
|
|
|
|
regulation of cellular component size
|
GO:0032535 |
121 |
0.016
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.016
|
|
|
|
positive regulation of vasculogenesis
|
GO:2001214 |
7 |
0.016
|
|
|
|
gtp catabolic process
|
GO:0006184 |
143 |
0.016
|
|
|
|
regulation of protein kinase b signaling
|
GO:0051896 |
56 |
0.016
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.016
|
|
|
|
response to insulin
|
GO:0032868 |
100 |
0.016
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.016
|
|
|
|
learning or memory
|
GO:0007611 |
148 |
0.016
|
|
|
|
gtp metabolic process
|
GO:0046039 |
144 |
0.016
|
|
|
|
transmission of nerve impulse
|
GO:0019226 |
76 |
0.016
|
|
|
|
positive regulation of nucleoside metabolic process
|
GO:0045979 |
91 |
0.016
|
|
|
|
response to peptide hormone
|
GO:0043434 |
127 |
0.016
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.016
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.016
|
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
128 |
0.016
|
|
|
|
cellular response to thyroid hormone stimulus
|
GO:0097067 |
1 |
0.016
|
|
|
|
response to hydrogen peroxide
|
GO:0042542 |
32 |
0.016
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.016
|
|
|
|
regulation of transmembrane transport
|
GO:0034762 |
128 |
0.016
|
|
|
|
cellular divalent inorganic cation homeostasis
|
GO:0072503 |
127 |
0.015
|
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
243 |
0.015
|
|
|
|
developmental growth involved in morphogenesis
|
GO:0060560 |
138 |
0.015
|
|
|
|
cellular response to oxidative stress
|
GO:0034599 |
76 |
0.015
|
|
|
|
regulation of calcium ion transport
|
GO:0051924 |
69 |
0.015
|
|
|
|
organelle assembly
|
GO:0070925 |
177 |
0.015
|
|
|
|
regulation of cell morphogenesis involved in differentiation
|
GO:0010769 |
151 |
0.015
|
|
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
138 |
0.015
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.015
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.015
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.015
|
|
|
|
fertilization
|
GO:0009566 |
127 |
0.015
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.015
|
|
|
|
positive regulation of sequence specific dna binding transcription factor activity
|
GO:0051091 |
68 |
0.015
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.015
|
|
|
|
endocrine system development
|
GO:0035270 |
98 |
0.015
|
|
|
|
platelet derived growth factor receptor beta signaling pathway
|
GO:0035791 |
4 |
0.015
|
|
|
|
rap protein signal transduction
|
GO:0032486 |
3 |
0.015
|
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.015
|
|
|
|
cellular protein complex assembly
|
GO:0043623 |
116 |
0.014
|
|
|
|
regulation of reactive oxygen species biosynthetic process
|
GO:1903426 |
2 |
0.014
|
|
|
|
microtubule cytoskeleton organization
|
GO:0000226 |
157 |
0.014
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.014
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.014
|
|
|
|
striated muscle contraction
|
GO:0006941 |
45 |
0.014
|
|
|
|
kit signaling pathway
|
GO:0038109 |
3 |
0.014
|
|
|
|
organic anion transport
|
GO:0015711 |
137 |
0.014
|
|
|
|
angiogenesis involved in coronary vascular morphogenesis
|
GO:0060978 |
2 |
0.014
|
|
|
|
cellular calcium ion homeostasis
|
GO:0006874 |
119 |
0.014
|
|
|
|
positive regulation of cytosolic calcium ion concentration
|
GO:0007204 |
65 |
0.014
|
|
|
|
regulation of nucleotide catabolic process
|
GO:0030811 |
122 |
0.014
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
148 |
0.014
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.014
|
|
|
|
protein localization to membrane
|
GO:0072657 |
108 |
0.014
|
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.014
|
|
|
|
response to radiation
|
GO:0009314 |
165 |
0.014
|
|
|
|
cellular response to peptide hormone stimulus
|
GO:0071375 |
92 |
0.014
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.014
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.014
|
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
126 |
0.014
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.014
|
|
|
|
calcium ion transmembrane transport
|
GO:0070588 |
85 |
0.014
|
|
|
|
sequestering of calcium ion
|
GO:0051208 |
18 |
0.014
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.014
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.013
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.013
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.013
|
|
|
|
production of molecular mediator of immune response
|
GO:0002440 |
103 |
0.013
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.013
|
|
|
|
organelle fission
|
GO:0048285 |
170 |
0.013
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.013
|
|
|
|
positive regulation of reactive oxygen species biosynthetic process
|
GO:1903428 |
2 |
0.013
|
|
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
106 |
0.013
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.013
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.013
|
|
|
|
spermatid development
|
GO:0007286 |
108 |
0.013
|
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
207 |
0.013
|
|
|
|
response to thyroid hormone
|
GO:0097066 |
2 |
0.013
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.013
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.013
|
|
|
|
metanephric glomerular mesangium development
|
GO:0072223 |
3 |
0.013
|
|
|
|
regulation of vesicle mediated transport
|
GO:0060627 |
139 |
0.013
|
|
|
|
organophosphate biosynthetic process
|
GO:0090407 |
122 |
0.013
|
|
|
|
organelle localization
|
GO:0051640 |
179 |
0.013
|
|
|
|
regulation of neuron death
|
GO:1901214 |
134 |
0.013
|
|
|
|
regulation of voltage gated calcium channel activity
|
GO:1901385 |
4 |
0.013
|
|
|
|
reactive oxygen species biosynthetic process
|
GO:1903409 |
8 |
0.013
|
|
|
|
cell migration involved in vasculogenesis
|
GO:0035441 |
2 |
0.013
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.013
|
|
|
|
memory
|
GO:0007613 |
58 |
0.013
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.012
|
|
|
|
leukocyte homeostasis
|
GO:0001776 |
79 |
0.012
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.012
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.012
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.012
|
|
|
|
response to macrophage colony stimulating factor
|
GO:0036005 |
3 |
0.012
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.012
|
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
234 |
0.012
|
|
|
|
nuclear division
|
GO:0000280 |
158 |
0.012
|
|
|
|
regulation of purine nucleotide catabolic process
|
GO:0033121 |
122 |
0.012
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.012
|
|
|
|
striated muscle myosin thick filament assembly
|
GO:0071688 |
1 |
0.012
|
|
|
|
platelet derived growth factor receptor alpha signaling pathway
|
GO:0035790 |
3 |
0.012
|
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.012
|
|
|
|
reactive nitrogen species metabolic process
|
GO:2001057 |
0 |
0.012
|
|
|
|
cellular response to acid chemical
|
GO:0071229 |
68 |
0.012
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.012
|
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
178 |
0.012
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.012
|
|
|
|
guanosine containing compound metabolic process
|
GO:1901068 |
144 |
0.012
|
|
|
|
myosin filament assembly
|
GO:0031034 |
2 |
0.012
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.012
|
|
|
|
engulfment of apoptotic cell
|
GO:0043652 |
3 |
0.012
|
|
|
|
protein glycosylation
|
GO:0006486 |
55 |
0.012
|
|
|
|
cellular response to organic cyclic compound
|
GO:0071407 |
87 |
0.012
|
|
|
|
smooth muscle cell chemotaxis
|
GO:0071670 |
2 |
0.012
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.012
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.012
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.012
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.012
|
|
|
|
spermatid differentiation
|
GO:0048515 |
115 |
0.012
|
|
|
|
positive regulation of growth
|
GO:0045927 |
104 |
0.012
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.011
|
|
|
|
response to reactive oxygen species
|
GO:0000302 |
56 |
0.011
|
|
|
|
myotube differentiation
|
GO:0014902 |
105 |
0.011
|
|
|
|
cytokinetic process
|
GO:0032506 |
2 |
0.011
|
|
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.011
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.011
|
|
|
|
action potential
|
GO:0001508 |
78 |
0.011
|
|
|
|
regulation of blood coagulation
|
GO:0030193 |
28 |
0.011
|
|
|
|
establishment or maintenance of cytoskeleton polarity
|
GO:0030952 |
2 |
0.011
|
|
|
|
myeloid cell homeostasis
|
GO:0002262 |
114 |
0.011
|
|
|
|
regulation of neuron projection development
|
GO:0010975 |
169 |
0.011
|
|
|
|
chromatin organization
|
GO:0006325 |
206 |
0.011
|
|
|
|
meiotic cell cycle
|
GO:0051321 |
122 |
0.011
|
|
|
|
regulation of cytoskeleton organization
|
GO:0051493 |
122 |
0.011
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.011
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.011
|
|
|
|
protein polymerization
|
GO:0051258 |
57 |
0.011
|
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
126 |
0.011
|
|
|
|
actin polymerization or depolymerization
|
GO:0008154 |
54 |
0.011
|
|
|
|
learning
|
GO:0007612 |
98 |
0.011
|
|
|
|
positive regulation of dna biosynthetic process
|
GO:2000573 |
4 |
0.011
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.011
|
|
|
|
sphingolipid catabolic process
|
GO:0030149 |
7 |
0.011
|
|
|
|
regulation of protein maturation
|
GO:1903317 |
96 |
0.011
|
|
|
|
glomerular mesangial cell proliferation
|
GO:0072110 |
3 |
0.011
|
|
|
|
muscle cell development
|
GO:0055001 |
133 |
0.010
|
|
|
|
plasma membrane organization
|
GO:0007009 |
90 |
0.010
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.010
|
|
|
|
regulation of cell size
|
GO:0008361 |
72 |
0.010
|
|
|
|
regulation of actin filament based process
|
GO:0032970 |
99 |
0.010
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.010
|
|
|
|
metanephric glomerular mesangial cell proliferation involved in metanephros development
|
GO:0072262 |
3 |
0.010
|
|
|
|
muscle system process
|
GO:0003012 |
141 |
0.010
|
|
|
|
mitotic cytokinesis
|
GO:0000281 |
4 |
0.010
|
|
|
|
neuron projection extension
|
GO:1990138 |
64 |
0.010
|
|
|
|
myosin filament organization
|
GO:0031033 |
3 |
0.010
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.010
|
|
|
|
dorsal ventral axon guidance
|
GO:0033563 |
3 |
0.010
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.010
|
|
|
|
covalent chromatin modification
|
GO:0016569 |
163 |
0.010
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.010
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.010
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.010
|
|